Korea Institute of Radiological Medical Science(KIRAMS) has signed licensing agreement with Wellmarker Bio(WMBIO) to transfer two biomarkers for anti-cancer drug on July 10, 2019.
Link: http://medipana.com/news/news_viewer.asp?NewsNum=242619&MainKind=A&NewsKind=5&vCount=12&vKind=1
Link: http://medipana.com/news/news_viewer.asp?NewsNum=242619&MainKind=A&NewsKind=5&vCount=12&vKind=1